Use of a novel human milk-based fortifier in a preterm baby

This article reports on the case of a premature baby with multiple complications who demonstrated poor weight gain and intolerance to bovine milk-based fortifier. A novel human milk-based fortifier (NeoKare MMF) was introduced, which was well tolerated and resulted in optimal weight gain. The course of the growth of the infant is discussed and the role of a human breast milk-derived fortifier is considered.

Pauline Adiotomre
Consultant Paediatrician
Neonatal Unit, Diana, Princess of Wales Hospital, Grimsby, Northern Lincolnshire and Goole NHS Foundation Trust
pauline.adiotomre@nhs.net

Full text available by subscription ...

The full text of this article is available to subscribers in text, and in Tablet/iPad format and as a PDF file.

Please subscribe and log in to see the full article.

Keywords

human breast milk-based fortifier; optimal weight gain; necrotising enterocolitis; premature infant; case study; cow’s milk intolerance

Key points

Use of a novel human milk-based fortifier contributed towards optimal weight gain in a preterm infant with multiple complications.
Human milk-based fortifier was used as a ‘rescue fortifier’ in a preterm infant with intolerance to bovine milk-based fortifier.

Also published in Infant:

VOLUME 16/ISSUE 1, JANUARY 2020

Full milk feeding from day one for preterm infants

The FEED1 trial will investigate whether full milk feeds from day 1 in infants born at 30⁺⁰ to 32⁺⁶ weeks’ gestation reduces the length of hospital stay when compared to intravenous fluids or parenteral nutrition with gradual milk feeding. Early establishment of milk feeding in preterm infants could reduce risks of infection and improve growth. Achieving fully nutritional volumes of milk feeds earlier and improving growth without infections or necrotising enterocolitis may help the infant to be ready for home sooner.